Status: current, Primitive. Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1461155012 | Daclizumab (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 1481091011 | Daclizumab | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclizumab | Is a | Immunosuppressant | true | Inferred relationship | Some | ||
| Daclizumab | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Daclizumab | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Daclizumab | Is a | Murine-human monoclonal IgG antibody | false | Inferred relationship | Some | ||
| Daclizumab | Has disposition | Murine-human monoclonal IgG antibody | false | Inferred relationship | Some | ||
| Daclizumab | Has disposition | Immunomodulator | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Daclizumab only product | Has active ingredient | True | Daclizumab | Inferred relationship | Some | 1 |
| Daclizumab only product in parenteral dose form | Has active ingredient | True | Daclizumab | Inferred relationship | Some | 1 |
| Daclizumab-containing product in parenteral dose form | Has active ingredient | True | Daclizumab | Inferred relationship | Some | 1 |
| Daclizumab-containing product | Has active ingredient | True | Daclizumab | Inferred relationship | Some | 1 |
| Daclizumab 25mg/5 mL solution | Has active ingredient | False | Daclizumab | Inferred relationship | Some | |
| Daclizumab 25mg/5mL infusion concentrate | Has active ingredient | False | Daclizumab | Inferred relationship | Some | |
| Daclizumab 25mg/5mL conventional release solution for injection | Has active ingredient | False | Daclizumab | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
FHIR